HIF1α activation disrupts the balance between glycolysis and fatty acid oxidation, promoting a “compensation-inhibitory model” wherein depleted core metabolic functions are compensated by other genes while non-essential pathways are suppressed (54), thereby exacerbating obesity. The gene discussed is HIF1A; the disease is obesity disorder.